Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine 2003 June;47(2) > The Quarterly Journal of Nuclear Medicine 2003 June;47(2):129-38

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Share

 

ORIGINAL ARTICLES   

The Quarterly Journal of Nuclear Medicine 2003 June;47(2):129-38

Copyright © 2009 EDIZIONI MINERVA MEDICA

language: English

Importance of radio-guided minimally invasive parathyroidectomy using hand-held γ probe and low 99mTc-MIBI dose. Technical considerations and long-term clinical results

Rubello D. 1, Casara D. 1, Giannini S. 2, Piotto A. 3, De Carlo E. 4, Muzzio P. C. 5, Pelizzo M. R. 2

1 2nd Nuclear Medicine Service, General Hospital of Padova, Padova, Italy 2 1st Clinical Medicine Institute, University of Padova, Padova, Italy 3 3rd Clinical Surgery Institute, University of Padova, Padova, Italy 4 3rd Clinical Medicine Institute, University of Padova, Padova, Italy 5 Oncological Radiology, University of Padova, Padova, Italy


PDF


Aim. 99mTc-­MIBI ­radio-­guided sur­gery ­results, ­obtained in a ­group of 141 ­patients ­with pri­mary hyper­pa­rath­yr­oi­dism (HPT), are ­reported.
­Methods. All ­patients ­were pre­op­er­a­tively eval­u­ated by a ­single day pro­tocol ­based on ­double-­tracer para­thy­roid scin­tig­raphy and ­neck ultra­sound, and ­then oper­ated by the ­same sur­gical ­team. In 102 ­patients (72.3%) ­with a ­high ­scan/ultra­sound prob­ability of sol­i­tary para­thy­roid ­adenoma and ­normal thy­roid ­gland, a min­i­mally inva­sive ­radio-­guided sur­gery was ­planned. In the ­other 39 ­patients (27.7%) ­with ­scan/ultra­sound evi­dence of ­multi-glan­dular dis­ease (n=8) or con­com­i­tant nod­ular ­goiter (n=31), the intra­op­er­a­tive γ ­probe was ­used ­during a stan­dard bilat­eral ­neck explo­ra­tion. Intra­op­er­a­tive ­quick para­thy­roid hor­mone (PTH) ­levels ­were rou­tinely meas­ured. The min­i­mally inva­sive ­radio-­guided sur­gery tech­nique we devel­oped, con­sisted of: a) injec­tion of a low 37 MBq 99mTc-­MIBI ­dose in the oper­a­tive ­theatre ­during ­anaesthesia induc­tion, b) ­patient’s ­neck ­scan ­with a ­hand-­held ­γ ­probe ­just ­before the sur­gical cut to ­localize the cuta­neous pro­jec­tion of the para­thy­roid ­adenoma, c) ­intraoper­a­tive ­probe detec­tion of the para­thy­roid ­adenoma and its ­removal ­through a ­small 2-2.5 cm ­skin inci­sion.
­Results. Min­i­mally inva­sive ­radio-­guided sur­gery was suc­cess­fully per­formed in 99/102 ­patients (97.0%). The ­γ ­probe was par­tic­u­larly ­useful in ­patients ­with an ­ectopic para­thy­roid ­adenoma in the ­upper med­i­as­tinum (n=11) or to the ­carotid bifur­ca­tion (n=1) or ­located ­deep in the ­neck (n=8). Min­i­mally inva­sive ­radio-­guided sur­gery was ­also ­obtained in 18/23 ­patients who had pre­vi­ously under­gone thy­roid/para­thy­roid sur­gery. The ­mean oper­a­tive ­time for min­i­mally inva­sive ­radio-­guided sur­gery was 38 min. No ­major sur­gical com­pli­ca­tion was ­recorded. Con­ver­sion to bilat­eral ­neck explo­ra­tion was ­required in ­only 3 ­cases ­because of ­intra-oper­a­tive diag­nosis of para­thy­roid car­ci­noma (n=2), and per­sis­tence of ele­vated ­quick PTH ­levels ­after ­removal of the pre­op­er­a­tively vis­u­al­ized para­thy­roid ­adenoma (n=1). ­Among ­patients ­treated by stan­dard bilat­eral ­neck explo­ra­tion, the ­γ probe was ­useful in local­izing a thym­ical ­enlarged para­thy­roid ­gland in 1 ­patient ­with ­multi-glan­dular dis­ease, a para­thy­roid ­adenoma ­located ­deep in the ­neck in 4 ­patients ­with con­com­i­tant nod­ular ­goiter and an ­ectopic para­thy­roid ­adenoma to the ­carotid bifur­ca­tion in ­another. How­ever, in ­some ­other ­patients ­with a para­thy­roid ­adenoma ­located ­near to the thy­roid, it was dif­fi­cult to ­intraoper­a­tively dis­tin­guish the para­thy­roid ­adenoma ­from a ­MIBI ­avid thy­roid ­nodule.
Con­clu­sion. It can be con­cluded ­that: (a) in pri­mary HPT ­patients ­with ­high ­scan/ultra­sound prob­ability of sol­i­tary para­thy­roid ­adenoma and ­normal thy­roid ­gland, the ­γ ­probe ­appears to be an effec­tive, ­rapid and ­safe tech­nique to per­form min­i­mally inva­sive ­radio-­guided sur­gery; b) a 99mTc-­MIBI ­dose as low as 37 MBq ­appears to be ade­quate to suc­cess­fully per­form ­radio-­guided sur­gery; c) the meas­ure­ment of ­quick PTH is rec­om­mended ­during min­i­mally inva­sive ­radio-­guided sur­gery; d) min­i­mally inva­sive ­radio-­guided sur­gery can be per­formed ­also in HPT ­patients ­with pre­vious para­thy­roid/thy­roid sur­gery ­thus lim­iting sur­gical ­trauma; e) ­with the pos­sible excep­tion of para­thy­roid ­adenoma ­located in ­ectopic ­sites or ­deep in the ­neck, the γ ­probe tech­nique ­does not ­seem rec­om­mend­able in HPT ­patients ­with con­com­i­tant nod­ular ­goiter.

top of page